ALFA Finder| Metric | Q1 FY27 | Q4 FY26 | Q1 FY26 |
|---|---|---|---|
| Revenue from operations | 250.3 | 246.6 | 186.7 |
| Other income | 3.9 | 1.0 | 1.2 |
| Total income | 254.2 | 247.5 | 187.9 |
| Profit before exceptional items & tax | 23.3 | 15.8 | 14.3 |
| Profit before tax | 23.3 | 15.8 | 14.3 |
| Net profit | 17.1 | 11.4 | 10.3 |
| Operating margin | 9.2% | 6.4% | 7.6% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | +66.00% |
|---|---|
| Net profit, quarter on quarter | +50.00% |
| Revenue, year on year | +34.10% |
| Operating profit, year on year | +45.10% |
| Operating profit, quarter on quarter | +26.90% |
NSE results filing, NSE: NEOGEN. Figures extracted from the filing.
Neogen Chemicals Ltd: key numbers
- Share price
- ₹2,856.30
- Market cap
- ₹8,581 Cr
- Revenue (annual)
- ₹862.0 Cr
- Net profit (annual)
- ₹28.75 Cr
- P/E (TTM)
- 212.3×Sector 29.3×
- Promoter holding
- 48.31%-4.70% QoQ
- FII holding
- 4.13%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Neogen Chemicals Ltd
All →Neogen Chemicals Regulatory Approval
Neogen Chemicals received GPCB's revocation of its Dahej plant direction and a CC&A amendment for manufacturing. The revocation is for three months with conditions attached.
Neogen Chemicals Other Announcement
A HUF of a director of Neogen's wholly owned subsidiary sold 2,361 shares on 5-6 November 2026. Sale consideration totals about ₹0.59 crore.
- Value
- ₹0.59 Cr
Neogen Chemicals Annual General Meeting
Neogen Chemicals seeks shareholder approval via postal ballot for related party transactions with a step-down subsidiary. E-voting runs until December 6, 2026.
Neogen Chemicals Earnings Call Transcript: Key Takeaways
Revenue rose 42% to ₹296 Cr and consolidated PAT rose 144% to ₹8 Cr, but a large standalone-to-consolidated gap shows the Neogen Ionics drag. Net debt is ₹1,095 Cr, and management gave no hard quarterly target to test against.
Neogen Chemicals Investor Presentation: Key Takeaways
Q2 FY27 consolidated revenue INR 296 Cr (+42%), EBITDA INR 45 Cr (+51%), PAT INR 8 Cr (+144%). Battery Chemicals revenue INR 37 Cr; Organolithium capacity expansion approved.
Neogen Chemicals Results Update
Neogen Chemicals issued its Q2 FY27 press release on unaudited results, showing higher year-on-year revenue and profit. Battery chemicals ramp-up and the QIP proceeds featured prominently.